Martin Kristensson is a seasoned professional with extensive experience in the biomedical engineering and clinical commercial strategy sectors. Currently serving as an Advisor and Board member at SENS Innovation ApS since January 2022, Martin has previously held significant roles at Visiopharm from March 2011 to September 2024, including Senior Vice President of Clinical Commercial Strategy and Sales Europe, where responsibilities encompassed global business development and management of commercial activities across Europe and Asia. In addition to venture partnership at CVX Ventures from January 2020 to June 2024, Martin has a solid academic background with dual M.Sc. degrees from the Technical University of Denmark and the University of Copenhagen, along with previous positions in research and teaching assistants at renowned institutions.